Identification and Distribution of 14.3.3σ (Stratifin) in the Human Cornea

REFERENCES

• Oliva M S, Taylor H. Ultraviolet radiation and the eye. Int Ophthalmol Clin 2005; 45(1)1–17, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lee G A, Hirst L W. Ocular surface squamous neoplasia. Surv Ophthalmol 1995; 39(6)429–450, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shields C L, Shields J A. Tumors of the conjunctiva and the cornea. Surv Ophthalmol 2004; 49(1)3–24, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mhawech P. 14.3.3 proteins—an update. Cell Res 2005; 15(4)228–236, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Wilker E, Yaffe M B. 14.3.3 proteins—a focus on cancer and human disease. J Mol Cell Cardiol 2004; 37: 633–642, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chan T A, Hermeking H, Lengauer C, et al. 14.3.3σ is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401(6753)616–620, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lodygin D, Diebold J, Hermeking H. Prostate cancer is characterized by epigenetic silencing of 14.3.3σ expression. Oncogene 2004; 23: 9034–9041, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lodygin D, Yazdi A S, Sander C A, et al. Analysis of 14.3.3σ expression in hyper-proliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 2003; 22: 5519–5524, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Ferguson A T, Evron E, Umbricht C B, et al. High frequency of hypermethylation at the 14.3.3σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000; 97: 6049–6054, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Guweidhi A, Kleeff J, Giese N, et al. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 2004; 25(9)1575–1585, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Nakanishi K, Hashizume S, Kato M, et al. Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. Hum Antibodies 1997; 8(4)189–194, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hermeking H. Extracellular 14.3.3σ protein: a potential mediator of epithelial-mesenchymal interactions. J Invest Dermatol 2004; 124(1)ix–x, [CSA], [CROSSREF]
   Google Scholar
• Steely H T, Jr, Clark A F. The use of proteomics in ophthalmic research. Pharmacogenomics 2000; 1(3)267–280, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Karring H, Thogersen I B, Klintworth G K, et al. Proteomic analysis of the soluble fraction from human corneal fibroblasts with reference to ocular transparency. Mol Cell Proteomics 2004; 3(7)660–674, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Karring H, Thøgersen I, Klintworth G, et al. A dataset of human cornea proteins identified by peptide mass fingerprinting and tandem mass spectrometry. Mol Cell Proteomics 2005; 4(9)1406–1408, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of protein silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850–858, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Van Hemert M J, Niemantsverdriet M, Schmidt T, et al. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14.3.3σ and 14.3.3ζ. J Cell Sci 2004; 117: 1411–1420, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ghahary A, Marcoux Y, Karimi-Busheri F, et al. Differentiated keratinocyte-releasable stratifin (14.3.3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005; 124: 170–177, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Joyce N C, Meklir B, Joyce S J, Zieske J D. Cell cycle protein expression and proliferative status in human corneal cell. Invest Ophthalmol Vis Sci 1996; 37(4)645–655, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Sibay T M, Basu P K, Rewcastle N B. Experimental production of corneal tumour. Can J Ophthalmol 1968; 3: 368–372, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hermeking H, Lengauer C, Polyak K, et al. 14.3.3σ is a p53-regulted inhibitor of G2/M progression. Mol Cell 1997; 1: 3–11, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wang L, Dai W, Lu L. Ultraviolet irradiation-induced K+ channel activity involving p53 activation in corneal epithelial cells. Oncogene 2005; 24: 3020–3027, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Benziger A, Muster N, Koch H B, et al. Targeted proteomic analysis of 14.3.3σ, a p-53 effector commonly silenced in cancer. Mol Cell Proteomics 2005; 4: 785–795, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Lam E, Kilani R T, Li Y, et al. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 2005; 125: 230–238, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ghaffari A, Li Y, Karami A, et al. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J Cell Biochem 2006; 98(2)383–393, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Collier S A, Madigan M C, Penfold P L. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas. Curr. Eye Res 2000; 21(2)662–668, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Netto M V, Mohan R R, Sinha S, et al. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res 2006; 82(5)788–797, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Fini E. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Ret Eye Res 1999; 18(4)529–551, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar